Recombinant Factor VIIa plus Surgery for Intracerebral Hemorrhage

Background: Hyperacute surgical evacuation of intracerebral hemorrhage is associated with a high rebleeding rate. The peri-operative administration of rFVIIa to patients with intracerebral hemorrhage may decrease the frequency of post-operative hemorrhage, and improve outcome. Methods: Patients receiving recombinant activated factor VII (rFVIIA) therapy immediately prior to acute surgery were collected at two centres. The intracerebral hemorrhage (ICH) score and ICH Grading Scale were determined, as was long-term outcome using the modified Rankin Scale. Residual/ recurrent clot was evaluated by comparing pre-operative to post-operative CT scans. Results: Fifteen patients with intracerebral hemorrhage received 40-90 μg/kg of rFVIIa and underwent surgical hematoma evacuation at a median time of five hours following symptom onset. Median pre-operative clot volume was 60 ml, decreasing to 2 ml post-operatively. There were no thromboembolic adverse events. Thirteen patients survived, 11 (73%) were independent, and two (13%) had a moderate to severe disability. These outcomes were significantly better than expected based on the median ICH score (40% mortality) and based on median ICH Grading Scale (18% good outcome). Conclusions: The pre or peri-operative administration of rFVIIa resulted in minimal residual or recurrent hematoma volume and may be an important adjunct to surgery in patients with intracerebral hemorrhage.

[1]  A. Osborn.  CT Angiography “Spot Sign” Predicts Hematoma Expansion in Acute Intracerebral Hemorrhage , 2009 .

[2]  E. Chiquete,et al.  Grading Scale for Prediction of Outcome in Primary Intracerebral Hemorrhages , 2007, Stroke.

[3]  D. Gladstone,et al.  CT Angiography “Spot Sign” Predicts Hematoma Expansion in Acute Intracerebral Hemorrhage , 2007, Stroke.

[4]  S. Mayer,et al.  Recombinant Activated Factor VII for Acute Intracerebral Hemorrhage , 2007, Stroke.

[5]  G. Chang.  Hematoma growth is a determinant of mortality and poor outcome after intracerebral hemorrhage , 2006, Neurology.

[6]  S M Davis,et al.  Hematoma growth is a determinant of mortality and poor outcome after intracerebral hemorrhage , 2006, Neurology.

[7]  G. Sutherland,et al.  Primary intracerebral hemorrhage: pathophysiology. , 2005, The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques.

[8]  A. Mendelow,et al.  Early Surgery Versus Initial Conservative Treatment in Patients With Spontaneous Supratentorial Intracerebral Hematomas in the International Surgical Trial in Intracerebral Hemorrhage (STICH): A Randomized Trial , 2005 .

[9]  A David Mendelow,et al.  Early surgery versus initial conservative treatment in patients with spontaneous supratentorial intracerebral haematomas in the International Surgical Trial in Intracerebral Haemorrhage (STICH): a randomised trial , 2005, The Lancet.

[10]  E. Beghi,et al.  Incidence of first‐ever ischemic and hemorrhagic stroke in a well‐defined community of southern Italy, 1993–1995 , 2003, European journal of neurology.

[11]  D. Corbett,et al.  Intracerebral hemorrhage induces macrophage activation and matrix metalloproteinases , 2003, Annals of neurology.

[12]  J. Lodder,et al.  Stereotactic Treatment of Intracerebral Hematoma by Means of a Plasminogen Activator: A Multicenter Randomized Controlled Trial (SICHPA) , 2003, Stroke.

[13]  A. Demchuk,et al.  Rebleeding leads to poor outcome in ultra-early craniotomy for intracerebral hemorrhage , 2001, Neurology.

[14]  Andreas Unterberg,et al.  Surgical treatment of intracerebral haemorrhage , 2007, British medical bulletin.

[15]  A. Mendelow,et al.  Surgery in Intracerebral Hemorrhage: The Uncertainty Continues , 2000, Stroke.

[16]  A. Mendelow,et al.  Continuous monitoring of ICP and CPP following ICH and its relationship to clinical, radiological and surgical parameters. , 2000, Acta neurochirurgica. Supplement.

[17]  A. Baxter,et al.  Extravasation of radiographic contrast is an independent predictor of death in primary intracerebral hemorrhage. , 1999, Stroke.

[18]  H. van Loveren,et al.  Early surgical treatment for supratentorial intracerebral hemorrhage: a randomized feasibility study. , 1999, Stroke.

[19]  J. Grotta,et al.  Surgical treatment for intracerebral hemorrhage (STICH) , 1998, Neurology.

[20]  S. Slørdahl,et al.  Stroke unit treatment improves long-term quality of life: a randomized controlled trial. , 1998, Stroke.

[21]  O. Rønning,et al.  Stroke unit versus general medical wards, II: neurological deficits and activities of daily living: a quasi-randomized controlled trial. , 1998, Stroke.

[22]  J. Oliver,et al.  Platelet activity of high‐dose factor VIIa is independent of tissue factor , 1997, British journal of haematology.

[23]  G. Hankey,et al.  Surgery for primary intracerebral hemorrhage: is it safe and effective? A systematic review of case series and randomized trials. , 1997, Stroke.

[24]  J. Broderick,et al.  Early hemorrhage growth in patients with intracerebral hemorrhage. , 1997, Stroke.

[25]  Haruko Yamamoto,et al.  Enlargement of spontaneous intracerebral hemorrhage. Incidence and time course. , 1996, Stroke.

[26]  T Brott,et al.  The ABCs of measuring intracerebral hemorrhage volumes. , 1996, Stroke.

[27]  C. Anderson,et al.  Spectrum of primary intracerebral haemorrhage in Perth, Western Australia, 1989-90: incidence and outcome. , 1994, Journal of neurology, neurosurgery, and psychiatry.

[28]  W. T. Sawyer,et al.  Pharmacokinetics and pharmacodynamics of recombinant factor VIIa , 1994, Clinical pharmacology and therapeutics.

[29]  Y. Fujii,et al.  Hematoma enlargement in spontaneous intracerebral hemorrhage. , 1994, Journal of neurosurgery.

[30]  J. Broderick,et al.  Volume of Intracerebral Hemorrhage: A Powerful and Easy‐to‐Use Predictor of 30‐Day Mortality , 1993, Stroke.

[31]  P. Sandercock,et al.  Primary Intracerebral Haemorrhage in the Oxfordshire Community Stroke Project , 1993 .

[32]  Raul G Nogueira,et al.  Spontaneous intracerebral hemorrhage. , 1992, Neurosurgery clinics of North America.

[33]  I. Holme,et al.  Benefit of a stroke unit: a randomized controlled trial. , 1991, Stroke.

[34]  J. Olsson,et al.  Prognostic Parameters in Spontaneous Intracerebral Hematomas with Special Reference to Anticoagulant Treatment Subjects and Methods , 2022 .

[35]  J. Dartigues,et al.  Death and functional outcome after spontaneous intracerebral hemorrhage. A prospective study of 166 cases using multivariate analysis. , 1991, Stroke.

[36]  J. Reisch,et al.  Failure of surgery to improve outcome in hypertensive putaminal hemorrhage. A prospective randomized trial. , 1990, Archives of neurology.

[37]  A. Poranen,et al.  The treatment of spontaneous intracerebral hemorrhage. A prospective randomized trial of surgical and conservative treatment. , 1989, Journal of neurosurgery.

[38]  E Körner,et al.  Endoscopic surgery versus medical treatment for spontaneous intracerebral hematoma: a randomized study. , 1989, Journal of neurosurgery.

[39]  W. Mckissock,et al.  PRIMARY INTRACEREBRAL HÆMORRHAGE: A Controlled Trial of Surgical and Conservative Treatment in 180 Unselected Cases , 1961 .